Nvidia’s investment in AI-driven drug discovery could revolutionize biotech, highlighting AI’s growing role in diverse industries beyond tech.
The post Nvidia invests in Generate Biomedicines, targeting $1.8T market with AI-driven drug discovery appeared first on Crypto Briefing.